Primary lymphomas of bone

Anticancer Research

Volumn 26, Issue 1 A, 2006, Pages 325-337

  Kitsoulis, Panagiotis ^a   Vlychou, Marianna ^b   Papoudou Bai, Alexandra ^a   Karatzias, Georgios ^a   Charchanti, Antonia ^a   Agnantis, Niki John ^a   Bai, Maria ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

^b UNIVERSITY OF THESSALY   (Greece)

Author keywords

Bone; Lymphomas; Review

Indexed keywords

DOXORUBICIN;

B LYMPHOCYTE DIFFERENTIATION; BONE LYMPHOMA; BONE MARROW; BONE PAIN; CANCER CLASSIFICATION; CANCER RADIOTHERAPY; CANCER STAGING; CLINICAL FEATURE; GENE EXPRESSION; GERMINAL CENTER; HISTOGENESIS; HISTOLOGY; HODGKIN DISEASE; HUMAN; IMMUNOHISTOCHEMISTRY; LARGE CELL LYMPHOMA; LYMPHOMA; MULTIMODALITY CANCER THERAPY; NONHODGKIN LYMPHOMA; PLASMA CELL; PLASMACYTOMA; PRIORITY JOURNAL; PROGNOSIS; REVIEW;

BONE NEOPLASMS; HODGKIN DISEASE; HUMANS; LYMPHOMA, NON-HODGKIN;

EID: 32144456251     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (115)

1. Freeman C, Berg JW and Cutler SJ: Occurrence and prognosis of extranodal lymphomas. Cancer 29: 252-260, 1972.
2. Rosenberg SA, Diamond HD, Jaslowitz B and Craver LF: Lymphosarcoma: a review of 1269 cases. Medicine 40: 31-81, 1961.
3. Ostrowski ML, Unni KK, Banks PM, Shives TC, Evans RG, O'Connell MJ and Taylor WF: Malignant lymphoma of bone. Cancer 58: 2646-2655, 1986.
4. Fletcher C, Unni K and Mertens F: Pathology and Genetics of Tumours of Soft Tissue and Bone: WHO Classification of Tumours. Lyon, France: IARC, 2002.
5. Heubner-Chan D, Fernandes B, Yang G and Lim MS: An immunophenotypic and molecular study of primary large B-cell lymphoma of bone. Mod Pathol 14: 1000-1007, 2001.
6. Isaacson P and Norton A: Extranodal lymphoma in miscellaneous sites. In: Extranodal Lymphoma in Miscellaneous Sites. Isaacson P, Norton A (eds.). New York: Churchill Livingstone, pp. 289-298, 1994.
7. Oberling C: Les reticulosarcomes et les reticuloendotheliosarcomes de la moelle osseuse (sarcoma d'Ewing). Bull Assoc Fr Etud Cancer (Paris) 17: 259-296, 1928.
8. Parker F and Jackson H: Primary reticulum cell sarcoma of bone. Surg Gynecol Obster 68: 45-53, 1939.
9. Falini B, Binazzi R, Pileri S, Mori A, Bertoni F, Canino S, Fagidi M, Minelli O, Ciani C and Pellicioli P: Large cell lymphoma of bone: a report of three cases of B-cell origin. Histopathology 12: 177-190, 1988.
10. Kluin P, Slootweg P, Schuurman H, Go D, Rademakers L, Van der Putte S and Van Unnik J: Primary B-cell malignant lymphoma of the maxilla with a sarcomatous pattern and multilobated nuclei. Cancer 54: 1598-1605, 1984.
11. Pettit C, Zukerberg L, Gray M, Ferry JA, Rosenberg AE, Harmon DC and Harris NL: Primary lymphoma of bone: a B-cell neoplasm with high frequency of multilobated cells. Am J Surg Pathol 14: 329-334, 1990.
12. Pileri S, Montanari M, Falini B, Poggi S, Sabatini E, Baglioni P, Bacchini P and Bertoni F: Malignant lymphoma involving the mandible. Clinical, morphologic and immunohistochemical study of 17 cases. Am J Surg Pathol 14: 652-659, 1990.
13. Radaszkiewicz T and Hansmann ML: Primary high-grade malignant lymphoma of bone. Virchows Arch [A] 413: 269-274, 1988.
14. Jaffe E, Harris N and Vardiman J: Pathology and genetics. In: Kleihues P, Sobin L (eds.). Tumours of Haematopoietic and Lymphoid Tissues: World Health Organization Classification of Tumours. Lyon France: IARC, 2001.
15. Bacci G, Jaffe N, Emiliani E, Van Horn J, Manfrini M, Picci P, Bertoni F, Gherlinzoni F and Campanacci M: Therapy for primary non-Hodgkin's lymphoma of bone and a comparison of results with Ewing's sarcoma. Ten years' experience at the Istituto Ortopedico Rizzoli. Cancer 57: 1468-1472, 1986.
16. Bacci G, Ferraro A, Casadei R, Barbieri E, Avella M, Ferrari S, Bertoni F, Picci P, Ruggieri P and Biagini R: Primary lymphoma of bone: long term results in patients treated with vincristine-adriamycin-cyclophosphamide and local radiation. J Chemother 3: 189-193, 1991.
17. Mendenhall NP, Jones JJ, Kramer BS, Hudson TM, Carter RL, Ennekin WF, Marais RB and Million RR: The management of primary lymphoma of bone. Radiother Oncol 9: 137-145, 1987.
18. Baar J, Burkes RL, Bell R, Blackstein ME, Fernandes B and Langer F: Primary non Hodgkin's lymphoma of bone. A clinicopathologic study. Cancer 73: 1194-1199, 1994.
19. Fairbanks RK, Bonner JA, Inwards CY, Strickler JG, Habermann TM, Unni KK and Su J: Treatment of stage IE primary lymphoma of bone. Int J Radiat Oncol Biol Phys 28: 363-372, 1994.
20. Dubey P, Ha CS, Besa PC, Fuller L, Cabanillas F, Murray J, Hess MA and Cox JD: Localized primary malignant lymphoma of bone. Int J Radiat Oncol Biol Phys 37: 1087-1093, 1997.
21. Dosoretz DE, Murphy GF, Raymond AK, Doppke KP, Schiller AL, Wang CC and Suit HD: Radiation therapy for primary lymphoma of bone. Cancer 51: 44-46, 1983.
22. Clayton F, Butler JJ, Ayala AG, Ro LY and Zornoza J: Non-Hodgkin's lymphoma in bone. Cancer 60: 2494-2501, 1987.
23. Suryanarayan K, Shuster JJ, Donaldson SS, Hutchison RE, Murphy SB and Link MP: Treatment of localized primary non-Hodgkin's lymphoma of bone in children: a Pediatric Oncology Group study. J Clin Oncol 17: 456-459, 1999.
24. Dosoretz DE, Raymond AK, Murphy GF, Doppke KP, Schiller AL, Wang CC and Suit HD: Primary lymphoma of bone: the relationship of morphologic diversity to clinical behavior. Cancer 50: 1009-1014, 1982.
25. Jones D, Kraus MD and Dorfman DM: Lymphoma presenting as a solitary bone tumor. Am J Clin Pathol 111: 171-178, 1999.
26. Heyning FH, Hogendoorn PC, Kramer MH, Hermans J, Kluin-Nelemans JC, Noordijk EM and Kluin PM: Primary non-Hodgkin's lymphoma of bone: a clinicopathological investigation of 60 cases. Leukemia 13: 2094-2098, 1999.
27. Yuste AL, Segura A, Lopez-Tendero P, Girones R, Montalar J and Gomez-Codina J: Primary lymphoma of bone: a clinicopathological review and analysis of prognostic factors. Leuk Lymphoma 45: 853-855, 2004.
28. Luna-Ortiz K, Cervera-Ceballos E, Dominguez-Malagon H, Labardini-Mendez J, De la Garza-Salazar J, Herrera-Gomez A and Barrera-Franco JL: Primary lymphoma of bone. Rev Invest Clin 55: 502-506, 2003.
29. Brousse C, Baumelou E and Morel P: Primary tymphoma of bone: a prospective study of 28 cases. Joint Bone Spine 67: 446-510,2000.
30. Misgeld E, Wehmeier A, Kromeke O and Gattermann N: Primary non-Hodgkin's lymphoma of bone: three cases and a short review of the literature. Ann Hematol 82: 440-443, 2003.
31. De Leval L, Braaten KM, Ancukiewicz M, Kiggundu E, Delaney T, Mankin HJ and Harris NL: Diffuse large B-cell lymphoma of bone: an analysis of differentiation-associated antigens with clinical correlation. Am J Surg Pathol 27: 1269-1277, 2003.
32. Zinzani PL, Carrillo G, Ascani S, Barbieri E, Tani M, Paulli M, Stefoni V, Sabattini E, Alinari L, Binazzi R, Tura S, Baccarani M and Pileri SA: Primary bone lymphoma: experience with 52 patients. Haematologica 88: 280-285, 2003.
33. Deshmukh C, Bakshi A, Parikh P, Nair R, Pai V, Gupta S, Shaikh A, Muckaden M, Naresh K and Saikia T: Primary non-Hodgkin's lymphoma of the bone: a single institution experience. Med Oncol 21: 263-267, 2004.
34. Giannellli U, Patriarca C, Moro A, Ponzoni M, Giardini R, Massimino M, Alfano RM, Armiraglio E, Nuciforo P, Coggi G and Parafioriti A: Lymphomas of the bone: a pathological and clinical study of 54 cases. Int J Surg Pathol 10: 257-266, 2002.
35. Charousset C, Anract P, Carlioz B, Babinet A and Tomeno B: Primary bone lymphoma. Retrospective immunohistochemical study of 22 cases. Rev Chir Orthop Reparatrice Appar Mot 88: 439-448, 2002.
36. Stemberga V, Dobi-Babic R, Bosnar A, Cuculic D, Fuckar D, Stifter S, Kusec R, Marusic-Vrsalovic M and Jonjic N: Primary non-Hodgkin's lymphoma of the humerus following traumatic injury: case report. Hematol Oncol 21: 109-114, 2003.
37. Ueda T, Aozasa K, Ohsawa M, Yoshikawa H, Ushida A, Ono K and Matsumoto K: Malignant lymphomas of bone in Japan. Cancer 64: 2387-292, 1989.
38. Chan JKC, Ng C-S, Hui P-K, Leung WT, Sin VC, Lam TK, Chick KW and Lam WY: Anaplastic large cell Ki-1 lymphoma of bone. Cancer 68: 2186-2191, 1991.
39. Ostrowski ML, Inwards CY, Strickler JG, Witzig TE, Wenger DE and Unni KK: Osseous Hodgkin's disease. Cancer 85: 1166-1178, 1999.
40. Ozdemirli M, Fanburg-Smith JC, Hartmann D-P, Shad AT, Lage JM, Magrath IT, Azumi N, Harris NL, Cossman J and Jaffe ES: Precursor B-lymphoblastic lymphoma presenting as a solitary bone tumor and mimicking Ewing's sarcoma: a report of four cases and review of the literature. Am J Surg Pathol 22: 795-804, 1998.
41. Iravani S, Singleton TP, Ross CW and Schnitzer B: Precursor B-lymphoblastic lymphoma presenting as lytic bone lesions. Am J Clin Pathol 112: 836-843, 1999.
42. Vassallo J, Roessner A, Vollmer E and Grundmann E: Malignant lymphomas with primary bone manifestation. Pathol Res Pract 182: 381-389, 1987.
43. Stein ME, Kuten A, Gez E et al: Primary lymphoma of bone: a retrospective study -experience at the Northern Israel Oncology Center (1979-2000). Oncology 64: 322-327, 2003.
44. Baar J, Burkes R and Gosporadowicz M: Primary non-Hodgkin's lymphoma of bone. Semin Oncol 26: 270-275, 1999.
45. Mullignan ME, McRae GA and Murphey MD: Imaging features of primary lymphomas of bone. AJR 173: 1691-1697, 1999.
46. Jelinek JS, Murphey MD, Welker JA, Henshaw RM, Kransdorf MJ, Shmookler BM and Malawer MM: Diagnosis of primary bone tumors with image-guided percutaneous biopsy. Radiology 223: 731-737, 2002.
47. Krishnan A, Shirkhoda A, Tehranzadeh J, Armin AR, Irwin R and Les K: Primary bone lymphoma: radiographic-MR imaging correlation. Radiographies 23: 1371-1383, 2003.
48. Mengiardi B, Honneger B, Hodler J, Exner UG, Csherhati MD and Bryhlmann W: Primary lymphoma of the bone: MRI imaging and CT characteristics during and after successful treatment. AJR 184: 185-192, 2005.
49. Braunstein EM and White SJ: Non-Hodgkin lymphoma of bone. Radiology 135: 59-63, 1980.
50. Spagnoli I, Gattoni F and Viganotti G: Roentgenographic aspects of non-Hodgkin's lymphomas presenting with osseous lesions. Skeletal Radiol 8: 39-41, 1982.
51. Strokes S and Walz BJ: Pathological fracture after radiation therapy for primary non-Hodgkin's malignant lymphoma of bone. Int J Radiat Oncol Bio Phys 9: 1153-1115, 1983.
52. Philips WC, Kattapuram SV, Dorestz De, Raymond AK, Schiller AL, Murphy G and Wyshak G: Primary lymphoma of bone: relationship of radiographic appearance and prognosis. Radiology 144: 285-290, 1982.
53. Salter M, Sollacio RJ, Bernreuter WK and Weppelmann B: Primary lymphoma of bone: the use of MRI in pretreatment evaluation. Am J Clin Oncol 12: 101-105, 1989.
54. Tondini C, Zanini M, Lombardi F, Bengala C, Rocca A, Giardini R, Buzzoni R, Valagussa P and Bonnadona G: Combined modality treatment with primary CHOP chemotherapy followed by locoregional irradiation in stage I or II histologically aggressive non-Hodgkin's lymphomas. J Clin Oncol 11: 720-725, 1993.
55. Haussler MD, Fenstermacher MJ, Hohnston DA and Harle TS: MRI of primary lymphoma of bone: cortical disorder as a criterion for differential diagnosis. J Magn Reson Imag 9: 93-100, 1999.
56. Hicks DG, Gokan T, O'Keefe RJ, Totterman SM, Fultz PT, Judkins AR, Meyers SP, Rubens DJ, Sickel JZ and Rosier RN: Primary lymphoma of bone: correlation of magnetic resonance imaging features with cytokine production by tumor cells. Cancer 75: 973-980, 1995.
57. Sundaram M and McGuire MH: Computed tomography or magnetic resonance for evaluating the solitary tumor or tumor -like lesion of bone? Skeletal Radiol 17: 393-401, 1988.
58. Panicek DM, Schwartz LH, Heelan RT and Caravelli JE: Non-neoplastic causes of high signal intensity at T2-weighted MR imaging after treatment for musculoskeletal neoplasm. Skeletal Radiol 24: 185-190, 1995.
59. Vanel D, Lacombe MJ, Couanet D, Kalifa C, Spielman M and Genin J: Musculoskeletal tumors: follow-up with MR imaging after treatment with surgery and radiation therapy. Radiology 164: 243-245, 1987.
60. Melamed JW, Martinez S and Hoffman CJ: Imaging of primary multifocal osseous lymphoma. Skeletal Radiol 26: 35-41, 1997.
61. Stroszczynski C, Oellinger J, Hoste N, Spahn G, Amthauer H, Ricke J, Hoffmann KT, Eichstaedt H, Ludwig WD and Felix R: Staging and monitoring of malignant lymphoma of the bone comparison of Ga scintigraphy and MRI. J Nucl Med 40: 387-393, 1999.
62. Yuki M, Narabayashi I, Yamamoto K, Shimizu T, Tanaka Y, Tatsumi T and Komori T: Multifocal primary lymphoma of bone: scintigraphy and MRI findings before and after treatment. Radiat Med 18: 305-310, 2000.
63. Ludwig K: Musculoskeletal lymphomas. Radiologe 42: 988-992, 2002
64. 67Ga scintigraphies. Eur Radiol 14: 1074-1081, 2004.
65. Park YH, Choi SJ, Ryoo BY and Kim HT: PET imaging with F-18 Fluorodeoxyglucose for primary lymphoma of bone. Clin Nucl Med 30: 131-134, 2005.
66. Matthies A, Schuster SJ and Alvani A: Staging and monitoring response to treatment in primary non-Hodgkin's lymphoma of bone marrow using (18) Fluorodeoxyglucose positron emission tomography. Clin Lymphoma 1: 303-306, 2001.
67. 67Ga scintigraphy and CT for prediction of outcome after treatment. J Nucl Med 43: 1295-1303, 2002.
68. Barbieri E, Cammelli S, Mauro P, Perini F, Cazzola A, Neri S, Bunkheila F, Ferrari S, Brandoli V, Zinzani PL, Mercuri M and Bacci G: Primary non-Hodgkin's lymphoma of the bone: treatment and analysis of prognostic factors for stage I and stage II. Int J Radiat Oncol Biol Phys 59: 760-764, 2004.
69. De Camargo OP, dos Santos Machado TM, Croci AT, de Oliveira CR, Giannoti MA, Baptista AM, Caiero MT, Alves VA and Matsumoto LA: Primary bone lymphoma in patients treated between 1955 and 1999. Clin Orthop 397: 271-280, 2002.
70. Lewis VO, Primus G, Anastasi J, Doherty D, Montag AG, Peabody TD and Simon MA: Oncologic outcome of primary lymphoma of bone in adults. Clin Orthop 415: 90-97, 2003.
71. Fidias P, Spiro I, Sobczak M, Nielsen GP, Ruffolo EF, Mankin H, Suit HD and Harmon DC: Long-term results of combined modality therapy in primary bone lymphomas. Int J Radiat Oncol Biol Phys 45: 1213-1218, 1999.
72. Edeiken-Monroe B, Edeiken J and Kim EE: Radiologic concepts of lymphoma of bone. Radiol Clin North Am 28: 841-864, 1990.
73. Horan FT: Bone involvement in Hodgkin's disease: a survey of 201 cases. Br J Surg 56: 277-281, 1969.
74. Newcomer LN, Silverstein MB, Cadman EC, Farber LR, Bertino JR and Prosnitz LR: Bone involvement in Hodgkin's disease. Cancer 49: 338-342, 1982.
75. Bartl R, Frisch B, Burkhardt R, Huhn D and Pappenberger R: Assessment of bone marrow histology in Hodgkin's disease: correlation with clinical factors. Br J Haematol 51: 345-360, 1982.
76. Dorfman RF: Relationship of histology to site in Hodgkin's disease. Cancer Res 31: 1786-1793, 1971.
77. Ellis ME, Diehl LF, Granger E and Elson E: Trephine needle bone marrow biopsy in the initial staging of Hodgkin disease: sensitivity and specificity of the Ann Arbor staging procedure criteria. Am J Hematol 30: 115-120, 1989.
78. Rosenberg SA: Hodgkin's disease of the bone marrow. Cancer Res 31: 1733-1736, 1971.
79. Borg MF, Chowdhury AD, Bhoopal S and Benjamin CS: Bone involvement in Hodgkin's disease. Austral Radiol 37: 63-66, 1993.
80. Parker BR, Marglin S and Castellino RA: Skeletal manifestations of leukemia, Hodgkin disease and non-Hodgkin lymphoma. Semin Roentgenol 15: 302-315, 1980.
81. Braunstein EM: Hodgkin's disease of bone: radiographic correlation with the histologic classification. Radiology 137: 643-646, 1980.
82. Ozdemirli M, Mankin HJ, Aisenberg AC and Harris NL: Hodgkin's disease presenting as a solitary bone tumor. Cancer 77: 79-88, 1996.
83. Gross SB, Robertson WW Jr, Lange BJ, Bunin NJ and Drummond DS: Primary Hodgkin's disease of bone: a report of two cases in adolescents and review of the literature. Clin Orthop 283: 276-280, 1992.
84. Manoli A II, Blaustein JC and Pedersen HE: Sternal Hodgkin's disease: report of two cases. Clin Orthop 228: 20-25, 1988.
85. Chan K-W, Rosen G, Miller DR and Tan CTC: Hodgkin's disease in adolescents presenting as a primary bone lesion: a report of four cases and review of the literature. Am J Pediatr Hematol Oncol 4: 11-17, 1982.
86. Staudt LM: Gene expression physiology and pathophysiology of the immune system. Trends Immunol 22: 35-40, 2001.
87. Ramaswamy S and Golub TR: DNA microarrays in clinical oncology. J Clin Oncol 20: 1932-1941, 2002.
88. Davis RE, Brown KD, Siebenlist U and Staudt LM: Constitutive nuclear factor KappaB activity is required for survival of activated B cell-like diffuse large B cell lymphoma cells. J Exp Med 194: 1861-1874, 2001.
89. Alizadeh AA, Eisen MB, Davis RE, Ma C, Lossos IS, RosenwaldA, Boldrick JC, Sabet H, Tran T, Yu X, Powell JI, Yang L, Marti GE, Moore T, Hudson J, Lu L, Lewis DB, Tibshirani R, Sherlock G, Chan WC, Greiner TC, Weisenburger DD, Armitage JD, Warnke R, Levy R, Wilson W, Grever MR, Byrd JC, Botstein D, Brown PO and Staudt LM: Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403: 503-511, 2000.
90. Rosenwald A, Wright G, Chan WC, Connors JM, Campo E, Fischer RI, Gascoyne RD, Muller-Hermelink HK, Smeland EB, Giltnane JM, Hurt EM, Zhao H, Averett L, Yang L, Wilson WH, Jaffe ES, Simon R, Klausner RD, Powell J, Duffey PL, Longo DL, Greiner TC, Weisenburger DD, Sanger WG, Dave BJ, Lynch JC, Vose J, Armitage JO, Montserrat E, Lopez-Guillermo A, Grogan TM, Miller TP, LeBlanc M, Ott G, Kvaloy S, Delabie J, Holte H, Krajci P, Stokke T and Staudt LM: The use of molecular profiling to predict survival after chemotherapy for diffuse large B-cell lymphoma. N Engl J Med 346: 1937-1947, 2002.
91. Wright G, Tan B, Rosenwald A, Hurt EH, Wiestner A and Staudt LM: A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B-cell lymphoma. Proc Natl Acad Sci USA 19: 9991-9996, 2003.
92. Shipp MA, Ross KN, Tamayo P, Weng AP, Kutok JL, Aguiar RC, Gaasenbeek M, Angelo M, Reich M, Pinkus GS, Ray TS, Koval MA, Last KW, Norton A, Lister TA, Mesirov J, Neuberg DS, Lander ES, Aster JC and Golub TR: Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning. Nat Med 8: 68-74, 2002.
93. Tzankov A, Pehrs AC, Zimpfer A, Ascani S, Lugli A, Pileri S and Dirnhofer S: Prognostic significance of CD44 expression in diffuse large B cell lymphoma of activated and germinal center B cell-like types: a tissue microarray analysis of 90 cases. J Clin Pathol 56: 747-752, 2003.
94. Chiu KC, Fine M, Ikle D, Slovak ML and Arber DA: Telomerase activity and proliferation index in aggressive mature B-cell lymphoma: comparison to germinal center phenotypic markers. Hum Pathol 34: 1259-1264, 2003.
95. Colomo L, Lopez-Guillermo A, Perales M, Rives S, Martinez A, Bosch F, Colomer D, Falini B, Montserrat E and Campo E: Clinical impact of the differentiation profile assessed by immunophenotyping in patients with diffuse large B-cell lymphoma. Blood 101: 78-84, 2003.
96. Hans CP, Weisenburger DD, Greiner TC, Gascoyne RD, Delabie J, Ott G, Muller-Hermelink HK, Campo E, Braziel RM, Jaffe ES, Pan Z, Farihna P, Smith LM, Falini B, Banham AH, Rosenwald A, Staudt LM, Connors JM, Armitage JO and Chan WC: Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood 103: 275-282, 2003.
97. King BE, Chen C, Locker J, Kant J, Okuyama K, Falini B and Swerdlow SH: Immunophenotypic and genotypic markers of follicular center cell neoplasia in diffuse large B-cell lymphomas. Mod Pathol 13: 1219-1231, 2000.
98. Bai M, Agnantis NJ, Skyrlas A, Tsanou E, Kamina S, Galani V and Kanavaros P: Increased expression of the bcl6 and CD10 proteins is associated with increased apoptosis and proliferation in diffuse large B-cell lymphomas. Mod Pathol 16: 471-480, 2003.
99. Bai M, Skyrlas A, Agnantis NJ, Tsanou E, Kamina S, Galani V and Kanavaros P: Diffuse large B-cell lymphomas with germinal center B-cell-like differentiation immunophenotypic profile are associated with high apoptotic index, high expression of the proapoptotic proteins bax, bak and bid and low expression of the anti-apoptotic protein bcl-xl. Mod Pathol 17: 847-856, 2004.
100. Bai M, Skyrlas A, Agnantis NJ, Kamina S, Kitsoulis P and Kanavaros P: Cluster analysis of apoptosis-associated bcl2 family proteins in diffuse large B-cell lymphomas. Relations with the apoptotic index, the proliferation profile and the B-cell differentiation immunophenotypes. Anticancer Res 24: 3081-3084, 2004
101. Bai M, Skyrlas A, Agnantis NJ, Kamina S, Kitsoulis P and Kanavaros P: Relations between B-cell differentiation, apoptosis and proliferation in diffuse large B-cell lymphomas. Anticancer Res 25: 347-362, 2004
102. Stefanaki, K, Tzardi M, Kouvidou C, Rontogianni D, Bolioti S, Chaniotis V, Vlychou M, Delides G and Kanavaros P: Expression of p53, mdm2, p21, Rb, Ki67, bcl2 and bax proteins in lymphomas of the mucosa-associated lymphoid tissue. Anticancer Res 18: 2403-2408, 1998.
103. Kanavaros P, Stefanaki K, Vlachonickolis J, Rontogianni D, Antonakopoulos G, Arvanitis D, Gorgoulis V, Bai M and Agnantis NJ: Immunohistochemical expression of p53, p21, Rb, p16 and Ki67 proteins in multiple myelomas. Anticancer Res 20: 4619-4625, 2000.
104. Gronbaek K, de Nully Brown P, Moller MB, Nedergaard T, Ralfkiaer E, Moller P, Zeuthen J and Guldberg P: Concurrent disruption of p16INK4a and the ARF-p53 pathway predicts poor prognosis in aggressive non-Hodgkin's lymphoma. Leukemia 14: 1727-1735, 2001.
105. Sanchez-Beato M, Saez AI, Navas IC, Algara P, Sol Mateo M, Villuendas R, Sanchez-Aguilera A, Camacho FI, Sanchez E and Piris MA: Overall survival in aggressive B-cell lymphomas is dependent on the accumulation of alterations in p53, p16 and p27. Am J Pathol 159: 205-213, 2001.
106. Bai M, Vlachonikolis J, Agnantis NJ, Tsanou E, Dimou S, Nicolaides C, Stefanaki S, Pavlidis N and Kanavaros P: Low expression of p27 protein combined with altered p53 and Rb/p16 expression status is associated with increased expression of cyclin A and cyclin B1 in diffuse large B-cell lymphomas. Mod Pathol 14: 1105-1113, 2001.
107. Leoncini L, Lazzi S, Bellan C and Tosi P: Cell kinetics and cell cycle regulation in lymphomas. J Clin Pathol 55: 648-655, 2002
108. Sanchez-Beato M, Sanchez-Aguilera A and Piris MA : Cell cycle deregulation in B-cell lymphomas. Blood 101: 1220-1235, 2003.
109. Hirokawa M, Kawabata Y and Miura AB: Deregulation of apoptosis and a novel mechanism of defective apoptotic signal transduction in human B-cell lymphomas. Leuk Lymphoma 43: 243-249, 2002.
110. Bai M, Tsanou E, Agnantis NJ, Dimou D, Chaidos A, Skyrlas A, Dimou S, Vlychou M, Galani V and Kanavaros P: Expression of cyclin D3 and cyclin E and identification of distinct clusters of proliferative activity and apoptosis status in diffuse large B-cell lymphomas. Histol Histopathol 18: 449-457, 2003.
111. Smolewski P, Darzynkiewicz Z and Robak T: Caspase-mediated cell death in hematological malignancies: theoretical considerations, methods of assessment and clinical implications. Leuk Lymphoma 44: 1089-1104, 2003.
112. Kanavaros P, Stefanaki K, Vlachonikolis J, Eliopoulos G, Kakolyris S, Rontogianni D, Gorgoulis V and Georgoulias V: Expression of p53, p21/waf-1, bcl-2, bax, Rb and Ki-67 proteins in Hodgkin's lymphomas. Histol Histopathol 15: 445-453, 2000.
113. Kuppers R, Klein U, Schwering I, Distler V, Brauninger A, Cattoretti G, Tu Y, Stolovitzky GA, Califano A, Hansmann ML and Dalla-Favera R: Identification of Hodgkin Reed-Sternberg cell specific genes by gene expression profiling. J Clin Invest 111: 529-537, 2003
114. Garcia JF, Camacho FI, Morente M, Fraga M, Montalban C, Alvaro T, Bellas C, Castano A, Diez A, Flores T, Martin C, Martinez MA, Mazorra F, Menarguez J, Mestre MJ, Mollejo M, Saez AI, Sanchez L and Piris MA: Hodgkin and Reed-Sternberg cells harbor alterations in the major tumor suppressor pathways and cell-cycle checkpoints: analyses using tissue microarrays. Blood 101: 681-689, 2003.
115. Bai M, Tsanou E, Agnantis NJ, Kamina S, Grepi C, Stefanaki K, Rontogianni D, Galani V and Kanavaros P: Proliferation profile of classical Hodgkin's lymphomas. Increased expression of the protein cyclin D2 in Hodgkin and Reed-Sternberg cells. Mod Pathol 17: 1338-1345, 2004